Selected research
Industry Growth & Trends
Global Microorganisms Development Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Microorganisms Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Microorganisms Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Microorganisms Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Microorganisms Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Microorganisms Development Services market include BRAIN Biotech, WuXi Biologics, KBI Biopharma, Lonza, Evonik, Lallemand Inc, Creative Biogene, MDG Bio and Creative BioMart Microbe, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Microorganisms Development Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Microorganisms Development Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microorganisms Development Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microorganisms Development Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Microorganisms Development Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Microorganisms Development Services Market by Company
BRAIN Biotech
WuXi Biologics
KBI Biopharma
Lonza
Evonik
Lallemand Inc
Creative Biogene
MDG Bio
Creative BioMart Microbe
Meurice R&D
BOC Sciences
Esco Aster
Microorganisms Development Services Segment by Type
Gene Editing and Synthesis Services
Directed Evolution and Screening Services
Metabolic Pathway Reconstruction Services
Fermentation Process Development Services
Others
Microorganisms Development Services Segment by Application
Biopharmaceuticals
Food and Ingredients
Agriculture and Environment
Energy and Materials
Others
Microorganisms Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microorganisms Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microorganisms Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microorganisms Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Microorganisms Development Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Editing and Synthesis Services
- Directed Evolution and Screening Services
- Metabolic Pathway Reconstruction Services
- Fermentation Process Development Services
- Others
Applications
- Biopharmaceuticals
- Food and Ingredients
- Agriculture and Environment
- Energy and Materials
- Others
Companies covered
- BRAIN Biotech
- WuXi Biologics
- KBI Biopharma
- Lonza
- Evonik
- Lallemand Inc
- Creative Biogene
- MDG Bio
- Creative BioMart Microbe
- Meurice R&D
- BOC Sciences
- Esco Aster
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Microorganisms Development Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Microorganisms Development Services Market Size by Region (2021-2032)
- 1.4.1 Global Microorganisms Development Services Market Size by Region (2021-2026)
- 1.4.2 Global Microorganisms Development Services Market Size by Region (2027-2032)
- 1.5 Key Regions Microorganisms Development Services Market Size (2021-2032)
- 1.5.1 North America Microorganisms Development Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Microorganisms Development Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Microorganisms Development Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Microorganisms Development Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Microorganisms Development Services Market Size Growth Rate (2021-2032)
2 Microorganisms Development Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Gene Editing and Synthesis Services
- 2.1.2 Directed Evolution and Screening Services
- 2.1.3 Metabolic Pathway Reconstruction Services
- 2.1.4 Fermentation Process Development Services
- 2.1.5 Others
- 2.2 Global Microorganisms Development Services Market Size by Type
- 2.2.1 Global Microorganisms Development Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Microorganisms Development Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Microorganisms Development Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Microorganisms Development Services Market Size by Regions
- 2.3.1 North America Microorganisms Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Microorganisms Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Microorganisms Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Microorganisms Development Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Microorganisms Development Services Market Size Breakdown by Type (2021-2026)
3 Microorganisms Development Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceuticals
- 3.1.2 Food and Ingredients
- 3.1.3 Agriculture and Environment
- 3.1.4 Energy and Materials
- 3.1.5 Others
- 3.2 Global Microorganisms Development Services Market Size by Application
- 3.2.1 Global Microorganisms Development Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Microorganisms Development Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Microorganisms Development Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Microorganisms Development Services Market Size by Regions
- 3.3.1 North America Microorganisms Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Microorganisms Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Microorganisms Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Microorganisms Development Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Microorganisms Development Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Microorganisms Development Services Industry Trends
- 4.2 Microorganisms Development Services Industry Drivers
- 4.3 Microorganisms Development Services Industry Opportunities and Challenges
- 4.4 Microorganisms Development Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Microorganisms Development Services Revenue (2021-2026)
- 5.2 Global Microorganisms Development Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Microorganisms Development Services Key Company Headquarters & Area Served
- 5.4 Global Microorganisms Development Services Company, Product Type & Application
- 5.5 Global Microorganisms Development Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Microorganisms Development Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Microorganisms Development Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Microorganisms Development Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 BRAIN Biotech
- 6.1.1 BRAIN Biotech Company Information
- 6.1.2 BRAIN Biotech Business Overview
- 6.1.3 BRAIN Biotech Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 BRAIN Biotech Microorganisms Development Services Product Portfolio
- 6.1.5 BRAIN Biotech Recent Developments
- 6.2 WuXi Biologics
- 6.2.1 WuXi Biologics Company Information
- 6.2.2 WuXi Biologics Business Overview
- 6.2.3 WuXi Biologics Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 WuXi Biologics Microorganisms Development Services Product Portfolio
- 6.2.5 WuXi Biologics Recent Developments
- 6.3 KBI Biopharma
- 6.3.1 KBI Biopharma Company Information
- 6.3.2 KBI Biopharma Business Overview
- 6.3.3 KBI Biopharma Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 KBI Biopharma Microorganisms Development Services Product Portfolio
- 6.3.5 KBI Biopharma Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lonza Microorganisms Development Services Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 Evonik
- 6.5.1 Evonik Company Information
- 6.5.2 Evonik Business Overview
- 6.5.3 Evonik Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Evonik Microorganisms Development Services Product Portfolio
- 6.5.5 Evonik Recent Developments
- 6.6 Lallemand Inc
- 6.6.1 Lallemand Inc Company Information
- 6.6.2 Lallemand Inc Business Overview
- 6.6.3 Lallemand Inc Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Lallemand Inc Microorganisms Development Services Product Portfolio
- 6.6.5 Lallemand Inc Recent Developments
- 6.7 Creative Biogene
- 6.7.1 Creative Biogene Company Information
- 6.7.2 Creative Biogene Business Overview
- 6.7.3 Creative Biogene Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Creative Biogene Microorganisms Development Services Product Portfolio
- 6.7.5 Creative Biogene Recent Developments
- 6.8 MDG Bio
- 6.8.1 MDG Bio Company Information
- 6.8.2 MDG Bio Business Overview
- 6.8.3 MDG Bio Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 MDG Bio Microorganisms Development Services Product Portfolio
- 6.8.5 MDG Bio Recent Developments
- 6.9 Creative BioMart Microbe
- 6.9.1 Creative BioMart Microbe Company Information
- 6.9.2 Creative BioMart Microbe Business Overview
- 6.9.3 Creative BioMart Microbe Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Creative BioMart Microbe Microorganisms Development Services Product Portfolio
- 6.9.5 Creative BioMart Microbe Recent Developments
- 6.10 Meurice R&D
- 6.10.1 Meurice R&D Company Information
- 6.10.2 Meurice R&D Business Overview
- 6.10.3 Meurice R&D Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Meurice R&D Microorganisms Development Services Product Portfolio
- 6.10.5 Meurice R&D Recent Developments
- 6.11 BOC Sciences
- 6.11.1 BOC Sciences Company Information
- 6.11.2 BOC Sciences Business Overview
- 6.11.3 BOC Sciences Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 BOC Sciences Microorganisms Development Services Product Portfolio
- 6.11.5 BOC Sciences Recent Developments
- 6.12 Esco Aster
- 6.12.1 Esco Aster Company Information
- 6.12.2 Esco Aster Business Overview
- 6.12.3 Esco Aster Microorganisms Development Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Esco Aster Microorganisms Development Services Product Portfolio
- 6.12.5 Esco Aster Recent Developments
7 North America
- 7.1 North America Microorganisms Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Microorganisms Development Services Market Size by Country (2021-2026)
- 7.3 North America Microorganisms Development Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Microorganisms Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Microorganisms Development Services Market Size by Country (2021-2026)
- 8.3 Europe Microorganisms Development Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Microorganisms Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Microorganisms Development Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Microorganisms Development Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Microorganisms Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Microorganisms Development Services Market Size by Country (2021-2026)
- 10.3 South America Microorganisms Development Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Microorganisms Development Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Microorganisms Development Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Microorganisms Development Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst